Current Applications of Nanoparticles in Tuberculosis Therapeutics

Preview this chapter:

Current Applications of Nanoparticles in Tuberculosis Therapeutics, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815313260/chapter-5-1.gif

The global community is deeply concerned with the rapid spread of tuberculosis (TB), a highly contagious and potentially fatal disease. Current treatment regimens are often inadequate, leading to a poor quality of life. Moreover, the emergence of new antibiotics has necessitated the need for more effective therapeutic options. As such, research is being conducted around the world to develop novel strategies to combat TB, with nanotechnology playing a major role in these initiatives. Nanotechnology is an improved tool for existing treatments because of its unique properties and the capacity to enhance therapeutic efficacy. It is being used to target, deliver, and release drugs to infected tissue and cells to increase their absorption and efficacy. Nanoparticles (NPs) have also been shown to deliver anti-TB drugs to infected lungs, which may make the drugs more bioavailable and less harmful to the body as a whole. This book chapter provides a promising outlook on the potential uses of NPs for TB therapeutic development and serves as a guide for future research on infectious diseases.